Skip to Content
Biotechnology and health

Aging clocks aim to predict how long you’ll live

These clocks promise to measure biological age and help identify anti-aging drugs, but there are lingering questions over their accuracy.

Aging Clocks concept
Andrea Daquino

Age is much more than the number of birthdays you’ve clocked. Stress, sleep, and diet all influence how our organs cope with the wear and tear of everyday life. Factors like these might make you age faster or slower than people born on the same day. That means your biological age could be quite different from your chronological age—the number of years you’ve been alive. 

Your biological age is likely a better reflection of your physical health and even your own mortality than your chronological age. But calculating it isn’t nearly as straightforward. Scientists have spent the last decade developing tools called aging clocks that assess markers in your body to reveal your biological age.

The big idea behind aging clocks is that they’ll essentially indicate how much your organs have degraded, and thus predict how many healthy years you have left. Among the hundreds of aging clocks developed in the last decade, though, accuracy varies widely. And researchers are still grappling with a vital question: What does it mean to be biologically young?

Most aging clocks estimate a person’s biological age based on patterns of epigenetic markers—specifically, chemical tags called methyl groups that are layered onto DNA and affect how genes are expressed. The pattern of this methylation across thousands of sites on DNA seems to change as we age, although it’s not clear why.

Some clocks promise to predict life span by estimating how a person’s body has aged, while others act more like a speedometer, tracking the pace of aging. Clocks have been developed for specific organs of the body, and for multiple animal species.

Proponents of aging clocks are already trying to use them to show that anti-aging interventions can make individuals biologically younger. But we don’t yet know enough about clocks, or what they tell us, to make such claims. 

Tracking time

The first epigenetic aging clock was developed in 2011 when Steve Horvath at the University of California, Los Angeles, volunteered to participate in a study with his identical twin brother, Markus. The study was looking for epigenetic markers in saliva samples that might explain sexual orientation. (Steve is straight and Markus is gay.) 

As a biostatistician, Horvath offered to analyze the results and found no link to sexual orientation. But he also looked for links between the volunteers’ age and epigenetic markers. “I fell off my chair, because the signal was huge for aging,” he says. 

He found that patterns of methylation could predict a person’s age in years, although the estimates differed on average by around five years from each person’s chronological age.

Horvath has worked on aging clocks ever since. In 2013 he developed the eponymous Horvath clock, still among the best-known aging clocks today, which he calls a “pan-tissue” clock because it can estimate the age of pretty much any organ in the body. Horvath built the clock using methylation data from 8,000 samples representing 51 body tissues and cell types. With this data, he trained an algorithm to predict a person’s chronological age from a cell sample.

Other groups have developed similar clocks, and hundreds exist today. But Horvath estimates that fewer than 10 are widely used in human studies, primarily to assess how diet, lifestyle, or supplements might affect aging.

Measuring age

What can all these clocks tell us? It depends. Most clocks are designed to predict chronological age. But Morgan Levine at the Yale School of Medicine in New Haven, Connecticut, says: “To me, that’s not the goal. We can ask someone how old they are.” 

In 2018, Levine, Horvath, and their colleagues developed a clock based on nine biomarkers, including blood levels of glucose and white blood cells, as well as a person’s age in years.

They used data collected from thousands of people in the US as part of a different study, which followed the participants for years. The resulting clock, called DNAm PhenoAge, is better at estimating biological age than clocks based solely on chronological age, says Levine. 

A one-year increase in what Levine calls “phenotypic” age, according to the clock, is associated with a 9% increase in death from any cause, as well as an increased risk of dying from cancer, diabetes, or heart disease. If your biological age is higher than your chronological age, it’s fair to assume you’re aging faster than average, says Levine. 

But that might not be the case, says Daniel Belsky at the Columbia University Mailman School of Public Health in New York City. He says there are many reasons why biological age might exceed a person’s years.

Belsky and his colleagues have developed a tool to more accurately measure the rate of biological aging, based on work that tracked the health outcomes of 954 volunteers at four ages between their mid-20s and mid-40s. The researchers looked at biomarkers believed to indicate how well various organs are functioning, as well as others linked to general health. Then they developed an epigenetic “speedometer” to predict how these values would change over time.

Another popular clock, also developed by Horvath and his colleagues, is called GrimAge, in a nod to the Grim Reaper. Horvath claims it’s the best at predicting mortality, and he’s been applying it to his own blood samples. 

His results were consistent with his chronological age two years ago, he says, but when he ran another test around six months ago, his GrimAge was four years older than his age in years. That doesn’t mean Horvath has shaved four years off his life span—“You cannot directly relate it to how long you’ll live,” he says—but he thinks it means he’s aging faster than he should be, though he’s still puzzled as to why. 

Noisy clocks

Others have used changes in their results to infer that their rate of aging has slowed, usually after they started taking a supplement. But in many cases, the change can be explained by the fact that many epigenetic aging clocks are “noisy”—prone to random errors that distort their results. 

The problem is that at each area of the body where methyl groups attach to DNA, very slight changes take place over time. These subtle changes can be magnified by errors in methylation estimates. It ends up being a huge problem, says Levine, and results can wind up being off by decades. 

To answer this, they are “breaking apart” existing clocks and comparing them. They hope to work out what different clocks are measuring, and how to build better ones in the future. 

Levine and her colleagues have been working to get rid of this noise. She’s also trying to understand what aging clocks actually tell us. What does it really mean to have a lower biological age? And how can this knowledge be applied? 

While aging clocks may be a good indicator of your overall health, they simply aren’t accurate enough to count on in most cases. “I think they haven’t realized their full potential yet,” says Levine. 

That potential could lie in clinical health checks, says Horvath, where clocks could be used alongside tests of blood pressure and cholesterol to help people understand how fit and healthy they are, or whether they are at risk of disease. 

“Epigenetic clocks will never replace clinical markers, [but] the clocks add value to them,” he says. “I think five years from now we will have human blood-based clocks that are so valuable that they could be used [clinically].”

In the meantime, eating a healthy diet, avoiding smoking, and getting enough exercise remain some of the best ways to stave off the impacts of aging. We don’t need new aging clocks to prove that those strategies can help keep us well. 

Our readers selected aging clocks as the 11th breakthrough in a poll for our annual list of 10 Breakthrough Technologies. Explore our picks below.   

Deep Dive

Biotechnology and health

The Biggest Questions: What is death?

New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.

I received the new gene-editing drug for sickle-cell disease. It changed my life.

As a patient enrolled in a clinical trial for Vertex’s new treatment, I was among the first to experience CRISPR’s transformative effects.

The lucky break behind the first CRISPR treatment

Gene editing for sickle-cell is here. This is how researchers knew what DNA to change.

Medical microrobots that can travel inside your body are (still) on their way

Microrobots released into the body could bust up clots, deliver cancer drugs, and even guide listless sperm to their target.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.